Baird Medical Replaces Auditor Amid Ongoing Internal Control Weaknesses

Baird Medical Investment Holdings ( (BDMD) ) has issued an update.

Baird Medical Investment Holdings Limited, a China-based foreign private issuer reporting under U.S. securities rules, has its principal executive offices in Guangzhou and prepares financial statements under U.S. GAAP. The company is subject to SEC oversight and relies on independent registered public accounting firms to audit its annual financial results for investors.

On February 10, 2026, Baird Medical dismissed Kreit & Chiu CPA LLP as its independent auditor and appointed Guangdong Prouden CPAs GP for the audit of the year ended December 31, 2025. The company said Kreit & Chiu’s prior reports were clean and disclosed no disagreements, but it has identified material weaknesses in internal controls over financial reporting, particularly a shortage of U.S. GAAP-qualified staff and the absence of comprehensive accounting policies and documented controls.

Baird Medical noted that the new auditor had not been previously consulted on accounting or reporting matters and has been informed of the existing material weaknesses, which are treated as a reportable event. Kreit & Chiu confirmed to the SEC that it agrees with the company’s description of matters relating to its engagement, underscoring that the change in auditor comes against a backdrop of ongoing remediation needs in the company’s financial control environment.

More about Baird Medical Investment Holdings

Baird Medical Investment Holdings Limited is a China-based company listed in the United States as a foreign private issuer and reporting under Form 20-F. The company operates from Guangzhou in the People’s Republic of China and prepares its financial statements in accordance with U.S. GAAP and SEC reporting requirements for global investors.

Average Trading Volume: 127,027

Technical Sentiment Signal: Sell

Current Market Cap: $33.8M

See more data about BDMD stock on TipRanks’ Stock Analysis page.